GH1 and type 2 diabetes mellitus: In UCD‐T2DM rats, the clearest evidence for this effect can be assessed from fasting plasma triglyceride concentrations (Figure 4A) and hepatic TG content (Figure 4D), both of which were significantly reduced in LIRA and GH + LIRA rats, compared with CON rats.